Neurobo Pharmaceuticals IncEigentümerstruktur
| Preis (2024-05-01) | 52W Hoch | 52W Tief |
| 3.68 USD | 6,75 USD | 2,888 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 6 USD | 1 | 0 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 4.906.030 | 2,5 | 1,39 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Neurobo Pharmaceuticals Inc
Mitarbeiter 8
Handelsplatz NASDAQ
Ticker Symbol NRBO
IPO Datum 2016-08-05
Adresse 200 Berkeley Street, Boston, MA, United States, 02116
Webseite https://www.neurobopharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Hyung-Heon Kim | CEO, President, Principal Executive & Director |
| 2 | Mr. Marshall H. Woodworth | CFO, Principal Financial Officer & Principal Accounting Officer |
| 3 | Dr. Mi-Kyung Kim | Chief Scientific Officer |
| 4 | Mr. Robert Homolka | Senior Vice President of Clinical Operations |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Citadel Advisors Llc | 0,00% | 0,00 Mio. USD |
| 2 | Hudson Bay Capital Management LP | 0,00% | 0,00 Mio. USD |
| 3 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 4 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 5 | Tower Research Capital LLC | 0,00% | 0,00 Mio. USD |
| 6 | Wells Fargo & Co | 0,00% | 0,00 Mio. USD |
| 7 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 8 | Comerica Bank | 0,00% | 0,00 Mio. USD |
| 9 | Bank of America Corp | 0,00% | 0,00 Mio. USD |
| 10 | State Street Corporation | 0,00% | 0,00 Mio. USD |
| 11 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 12 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 13 | Two Sigma Investments LLC | 0,00% | 0,00 Mio. USD |
| 14 | Virtu Financial LLC | 0,00% | 0,00 Mio. USD |
| 15 | TWO SIGMA SECURITIES, LLC | 0,00% | 0,00 Mio. USD |